AXE
Director Trades
| Date | Director | Value |
|---|
Company News
Archer Materials Confirms Suitability of Silicon Foundation for Potassium-Sensing Biochip Device
Initial data from first-stage testing of Archer Materials’ (ASX: AXE) blood potassium graphene Biochip project have shown the technology suitable for silicon for point-of-care and at-home diagnostic applications. Archer expects the findings to de-risk its supply chain, reduce unit costs, and accelerate the pathway towards manufacture and commercialisation. The company is now on track to […]
Australia’s Semiconductor Future: Inside the Semiconductor Australia 2025 Conference
Small Caps readers can now access an exclusive 20% ticket discount via our website banner. Australia’s semiconductor sector is heating up, and the upcoming Semiconductor Australia 2025 Conference is set to showcase the nation’s brightest deep-tech innovators, cutting-edge research, and the investors driving the next wave of advanced manufacturing. Hosted in Sydney, the event brings together global […]
Archer Materials Advances Quantum Tech with Cryogenic TMR Sensor Demonstration
Semiconductor company Archer Materials (ASX: AXE) has completed the demonstration of highly-sensitive magnetic field measurements at cryogenic temperatures using its tunnel magnetoresistance (TMR) sensor technology. The work is part of the company’s 12CQ quantum project focused on developing a carbon-based quantum bit (qubit) semiconductor chip with high bandwidth and low power consumption to replace traditional […]
Archer Materials partners with Paragraf to accelerate development of potassium-sensing Biochip device
Archer Materials (ASX: AXE) has signed a $450,000 deal with UK-based graphene electronics company Paragraf to develop its Biochip potassium-sensing device for in-home testing of chronic kidney disease. The six-month project will accelerate technical progress towards meeting the blood potassium sensing target product profile using a graphene field-effect transistor (gFET). Both companies will leverage their […]
Archer Materials and Hylid Diagnostics partner to develop at-home potassium test for kidney disease
Archer Materials (ASX: AXE) has signed an agreement with Canadian medical device company Hylid Diagnostics to develop a potassium measurement product for at-home testing of chronic kidney disease. The partnership will combine Archer’s Biochip potassium-sensing technology with Hylid’s blood haemolysis sensor technology to develop a prototype at-home testing device that meets stringent accuracy requirements for […]
Archer Materials develops new carbon film with breakthrough quantum properties
Semiconductor developer Archer Materials (ASX: AXE) has manufactured a new carbon film with electron spin lifetimes exceeding those previously measured in carbon nano-onions (CNOs). The film was developed as part of the company’s ongoing work with academic researchers at the University of New South Wales to create a scale-up path and manufacturable methods for CNOs. […]
Archer Materials moves closer to scaled manufacture of 12CQ chip with new proof-of-concept devices
Archer Materials (ASX: AXE) has manufactured two proof-of-concept electrical devices to improve the data output of its spin materials and enhance development of its 12CQ quantum computer chip. The devices were created and characterised by Archer’s quantum team in partnership with academic researchers at the University of New South Wales using simulation software developed by […]
Archer Materials well-funded to advance qubit processor and biochip technologies
Archer Materials (ASX: AXE) closed out the December quarter 2022 (Q2 FY2023) well-funded with $24.3 million in cash to continue advancing its unique qubit processor and biochip technologies. The company is focused on progressing its 12CQ quantum computing qubit process chip (12CQ chip) and its “lab-on-a-chip” biochip. Archer’s 12CQ chip is being developed to enable […]
Archer Materials confirms uniqueness of 12CQ material with supercomputers
Archer Materials (ASX: AXE) has validated the uniqueness of its 12CQ quantum computing qubit material (12CQ material) after analysing it using some using some of the world’s most powerful supercomputers. According to Archer, the complex atom-structure of the 12CQ material requires the “enormous power” of supercomputers for predictive modelling and realistic simulations of its properties. […]
Archer Materials achieves ‘major milestone’ in development of integrated biochip platform
Archer Materials (ASX: AXE) has developed an early-stage prototype of an integrated biochip platform with automated liquid sample handling robotics and user readout. This work is considered a major milestone in the commercialisation of the company’s biochip technology. The platform will be used to quickly test inhouse biosensing chips to obtain the relevant data for […]
